Nicholas N. Vahanian
Geen lopende functies
Profiel
Nicholas N.
Vahanian was the founder who founded NewLink Genetics Corp.
in 1999 and held the titles of President, Director & Chief Medical Officer from 2015 to 2017.
He also worked as President at Lumos Pharma, Inc. in a former job.
Dr. Vahanian earned an MBA degree from the University of Notre Dame and an undergraduate degree from Virginia Commonwealth University.
Eerdere bekende functies van Nicholas N. Vahanian
| Bedrijven | Functie | Einde |
|---|---|---|
| LUMOS PHARMA, INC. | Oprichter | 11-11-2019 |
| LUMOS PHARMA, INC. | President | 27-09-2019 |
Opleiding van Nicholas N. Vahanian
| Virginia Commonwealth University | Undergraduate Degree |
| University of Notre Dame | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LUMOS PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
